Job/Unit: O21715
/KAP1
Date: 10-04-13 17:57:11
Pages: 10
Tuning the Halide Affinity of Quinoline-Based Anion Receptors
= 10.22 (s, 1 H), 9.48 (d, 1 H), 8.04 (s, 1 H), 7.89 (d, 1 H), 7.64 (s,
1 H), 7.52 (t, 1 H), 7.28 (m, 3 H), 7.20 (m, 5 H), 7.13 (d, 1 H), 7.04
(t, 1 H), 4.46 (d, 2 H), 3.96 (d, 2 H), 2.19 (m, 1 H), 1.04 (d, 6
H) ppm. 13C NMR (150 MHz, CDCl3): δ = 177.16, 164.32, 163.51,
149.38, 138.57, 138.13, 136.39, 134.33, 130.07, 128.61, 127.27,
127.24, 126.94, 126.79, 125.03, 122.05, 118.52, 116.89, 99.78, 75.37,
1.049; R1 = 0.0677 [IϾ2σ(I)]; ωR2 (all data) = 0.1556; peak/hole
ratio: 0.215/–0.206 eÅ–3.
4-Isobutoxy-N-(pentafluorobenzyl)-8-(pentafluorobenzylthioureido)-
quinoline-2-carboxamide (4): The synthesis of 4 was performed in a
manner similar to that used for 1. It was purified by recrystalli-
sation from dichloromethane/MeOH to allow isolation of the com-
pound as a yellow solid, yield 366 mg (54 %), m.p. 196 °C. 1H
NMR (300 MHz, CDCl3): δ = 8.99 (s, 1 H), 8.52 (t, 1 H), 8.03 (d,
2 H), 7.62 (s, 1 H), 7.53 (t, 1 H), 6.92 (t, 1 H), 4.96 (t, 2 H), 4.75
(d, 2 H), 3.99 (d, 2 H), 2.25 (m, 1 H), 1.12 (d, 6 H) ppm. 19F
NMR (282 MHz, CDCl3): δ = –142.22 (dd, 2 F), –142.58 (dd, 2
F), –153.88 (t, 1 F), –154.52 (t, 1 F), –161.41 (m, 2 F), –161.67 (m,
2 F) ppm. 13C NMR (75 MHz, CDCl3): δ = 181.31, 164.16, 163.53,
149.88, 147.21, 139.93, 133.81, 126.82, 123.05, 121.33, 119.02,
43.11, 28.10, 19.18 ppm. IR (KBr): ν = 3403, 3281, 3222, 2955,
˜
1664, 1528, 1346, 1227, 1160, 1051, 913, 861, 812, 755, 687 cm–1.
MS (ESI): m/z (%) = 507.18379 (100.00) [M + Na]+, 485.20196
(90.00) [C28H29N4O2S + H]+, 350.18738 (55.00) [C21H24N3O2]+.
C28H28N4O2S·1/2H2O (493.6): calcd. C 68.13, H 5.92, N 11.35;
found C 68.40, H 5.51, N 10.87. X-ray-quality crystals were ob-
tained from MeOH/dichloromethane: C28H28N4O2S; Mr = 484.60;
crystal size 0.27ϫ0.13ϫ0.05 mm3; monoclinic; space group P21/c
(No. 14); a = 8.0294(2) Å, b = 16.1218(4) Å, c = 19.8969(6) Å; β =
100.567 (1)°; V = 2531.94(12) Å3; Z = 4; ρcalcd. = 1.271 gcm–3; μ =
110.96, 99.63, 37.04, 31.56, 28.06, 19.12 ppm. IR (KBr): ν = 3320,
˜
3175, 2963, 1664, 1506, 1417, 1311, 1212, 1121, 1026, 965, 924,
763 cm– 1 . MS (ESI): m/z (%) = 679.17 (100) [M + H]+ .
C29H20F10N4O2S (678.54): calcd. C 50.33, H 2.97, N 8.26; found
C 51.22, H 2.96, N 8.25. X-ray-quality crystals were obtained from
MeOH/dichloromethane: C29H20F10N4O2S; Mr = 678.55; crystal
size 0.27ϫ0.13ϫ0.10 mm3; triclinic; space group P-1 (No. 2); a =
10.3605(3) Å, b = 12.1967(4) Å, c = 13.2370(4) Å; α = 108.120(1),
0.160 mm–1; F(000) = 1024; 7226 collected reflections (θmax
25.00°) of which 4340 were independent (Rint = 0.0251); Tmax
=
=
0.9920; Tmin = 0.9580; T = 223(2) K; full-matrix least-square on F2
with 0 restraint and 327 parameters; GOF = 1.057; R1 = 0.0573
[I Ͼ 2σ(I)]; ωR2(all data) = 0.1356; peak/hole ratio: 0.197/–
0.196 eÅ–3.
β = 108.706(2), γ = 99.221(3)°; V = 1441.59(8) Å3; Z = 2; ρcal
1.563 gcm–3; μ = 0.213 mm–1; F(000) = 688; 13439 collected reflec-
tions (θmax = 25.00°) of which 5000 were independent (Rint
=
4-Isobutoxy-N-(pentafluorobenzyl)-8-(pentafluorophenylthioureido)-
quinoline-2-carboxamide (2): The synthesis of 2 was performed in a
manner similar to that used for 1. The compound was purified by
recrystallisation from dichloromethane/MeOH to obtain a colour-
=
0.036); Tmax = 0.9790; Tmin = 0.9447; T = 223(2) K; full-matrix
least-square on F2 with 7 restraint and 426 parameters; GOF =
1.068; R1 = 0.0589 [IϾ2σ(I)]; ωR2 (all data) = 0.1496; peak/hole
ratio: 1.019/–0.518 eÅ–3.
1
less solid, yield 372 mg (56%), m.p. 167 °C. H NMR (300 MHz,
CDCl3): δ = 9.49 (s, 1 H), 8.55 (d, 1 H), 8.45 (t, 1 H), 8.08 (s, 1
H), 7.82 (d, 1 H), 7.44 (m, 2 H), 4.80 (d, 2 H), 3.86 (d, 2 H), 2.19
(m, 1 H), 1.09 (d, 6 H) ppm. 19F NMR (282 MHz, CDCl3): δ =
–142.72 (d, 2 F), –144.42 (d, 2 F), –154.08 (m, 1 F), –154.33 (t, 1
F), –161.56 (m, 2 F), –162.07 (d, 2 F) ppm. 13C NMR (75 MHz,
CDCl3): δ = 181.17, 165.17, 163.37, 149.80, 139.44, 133.71, 126.84,
122.37, 121.37, 118.95, 99.34, 31.66, 28.16, 19.04 ppm. IR (KBr):
N-Benzyl-4-isobutoxy-8-(phenylureido)quinoline-2-carboxamide (5):
The synthesis of 5 was performed in a manner similar to that used
for 1. The compound was purified by recrystallisation from di-
chloromethane/MeOH to allow isolation as a yellow solid, yield
314 mg (67%), m.p. 126 °C. 1H NMR (400 MHz, [D6]DMSO): δ =
9.66 (s, 1 H), 9.63 (t, 1 H), 9.27 (s, 1 H), 8.52 (dd, 1 H), 7.72 (dd,
1 H), 7.66 (s, 1 H), 7.57 (t, 1 H), 7.49 (m, 2 H), 7.32 (m, 7 H), 6.98
(t, 1 H), 4.67 (d, 2 H), 4.11 (d, 2 H), 2.19 (m, 1 H), 1.07 (d, 6
H) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 164.46, 163.13,
152.67, 149.65, 139.64, 137.65, 136.50, 129.35, 128.84, 128.26,
127.62, 127.36, 118.95, 115.97, 113.68, 99.63, 75.08, 43.07, 28.09,
ν = 3369, 2949, 2234, 1713, 1611, 1502, 1464, 1324, 1197, 1134,
˜
1099, 993, 842, 750 cm–1. MS (ESI): m/z (%) = 665.58 (60) [M +
H]+, 440.85 (100) [C21H18F5N3O2 + H]+. C28H18F10N4O2S
(664.52): calcd. C 50.61, H 2.73, N 8.43; found C 50.56, H 2.79, N
8.39.
N-Benzyl-8-(benzylthioureido)-4-isobutoxyquinoline-2-carboxamide
(3): The synthesis of 3 was performed in a manner similar to that
used for 1. It was purified by recrystallisation from dichlorometh-
ane/MeOH to allow isolation of the compound as a light-yellow
19.38 ppm. IR (KBr): ν = 3324, 2964, 1646, 1523, 1416, 1313, 1198,
˜
1071, 1001, 752, 690 cm–1. MS (ESI): m/z (%) = 491.20361 (100)
[M + Na]+. C28H28N4O3·1/2H2O (477.6): calcd. C 70.42, H 6.12,
N 11.73; found C 70.70, H 5.98, N 11.76.
1
solid, yield 339 mg (68%), m.p. 163 °C. H NMR (400 MHz, [D6]-
DMSO): δ = 9.16 (s, 1 H), 8.43 (s, 1 H), 8.18 (s, 1 H), 7.89 (dd, 1
H), 7.60 (s, 1 H), 7.43 (t, 1 H), 7.17 (m, 9 H), 6.77 (s, 1 H), 4.71 4-Isobutoxy-N-(pentafluorobenzyl)-8-(pentafluorophenylureido)quin-
(d, 2 H), 4.52 (d, 1 H), 3.87 (d, 2 H), 2.16 (m, 1 H), 1.01 (d, 6 oline-2-carboxamide (6): The synthesis of 6 was performed in a
H) ppm. 13C NMR (150 MHz, CDCl3): δ = 164.86, 163.38, 149.45,
manner similar to that used for 1. The compound was purified by
139.24, 137.62, 134.56, 128.64, 128.61, 127.80, 127.65, 127.44, recrystallisation from dichloromethane/MeOH to allow isolation as
127.20, 126.93, 122.60, 119.82, 117.30, 99.41, 75.12, 49.05, 43.39,
a colourless solid, yield 512 mg (79 %), m.p. 241 °C. 1H NMR
28.06, 19.13 ppm. IR (KBr): ν = 3289, 2084, 1647, 1544, 1460,
(400 MHz, [D6]DMSO): δ = 9.96 (s, 1 H), 9.53 (t, 1 H), 9.12 (s, 1
˜
1423, 1362, 1330, 1250, 1228, 1180, 1143, 1041, 857, 724, 692 cm–1. H), 8.46 (dd, 1 H), 7.79 (dd, 1 H), 7.64 (m, 2 H), 4.78 (d, 2 H),
MS (ESI): m/z (%) = 499.07 (99.68) [M + Na]+, 350.20 (100.00) 4.13 (d, 2 H), 2.21 (m, 1 H), 1.10 (d, 6 H) ppm. 19F NMR
[C21H24N3O2]+. C29H30N4O32S (978.62): calcd. C 69.85, H 6.06, N
(376 MHz, [D6]DMSO): δ = –142.41 (dd, 2 F), –146.17 (dd, 2 F),
11.24; found C 69.56, H 5.73, N 11.11. X-ray-quality crystals were –156.11 (t, 1 F), –159.31 (t, 1 F), –163.20 (m, 2 F), –163.85 (m, 2
obtained from MeOH/dichloromethane: C29H30N4O2S; Mr =
498.63; crystal size 0.37 ϫ 0.10 ϫ 0.06 mm3; monoclinic; space
group P21/c (No. 14); a = 8.2730(2) Å, b = 31.1994(4) Å, c =
20.2195(4) Å; β = 91.083(1)°; V = 5217.98(18) Å3; Z = 8; ρcalcd.
= 1.269 gcm–3; μ = 0.158 mm–1; F(000) = 2112; 16171 collected
F) ppm. IR (KBr): ν = 3310, 2969, 1685, 1644, 1561, 1501, 1461,
˜
1233, 1008, 980, 767, 745 cm–1. MS (ESI): m/z (%) = 649.00 (100)
[M + H]+. C28H18F10N4O3·H2O: calcd. C 50.46, H 3.03, N 8.41;
found C 50.71, H 3.19, N 8.57. X-ray-quality crystals were ob-
tained from DMSO: C28H18F10N4O3·(CH3)2SO; Mr = 726.59; crys-
tal size 0.53ϫ0.20ϫ0.10 mm3; monoclinic; space group P21/n (No.
14); a = 15.0156(3) Å, b = 9.5866(2) Å, c = 21.3804(5) Å; β =
92.722(1)°; V = 3074.21(11) Å3; Z = 4; ρcalcd. = 1.570 gcm–3; μ =
reflections (θmax = 25.00°) of which 9048 were independent (Rint
=
0.0491); Tmax = 0.9906; Tmin = 0.9440; T = 223(2) K; full-matrix
least-square on F2 with 0 restraint and 671 parameters; GOF =
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
7